Jeffrey Allen Bailey

Jeffrey Allen Bailey has an estimated net worth of $22.5 Million. This is based on reported shares across multiple companies, which include BIODELIVERY SCIENCES INTERNATIONAL INC, Lantheus Holdings, Inc., TEKLA HEALTHCARE INVESTORS, Tekla Healthcare Opportunities Fund, Tekla World Healthcare Fund, TEKLA LIFE SCIENCES INVESTORS, LANDAUER INC, AILERON THERAPEUTICS INC, KING PHARMACEUTICALS INC, and Aurinia Pharmaceuticals Inc..

2020 was Jeffrey Allen Bailey's most active year for acquiring shares with 15 total transactions. Jeffrey Allen Bailey's most active month to acquire stocks was the month of October. 2022 was Jeffrey Allen Bailey's most active year for disposing of shares, totalling 8 transactions. Jeffrey Allen Bailey's most active month to dispose stocks was the month of February. 2022 saw Jeffrey Allen Bailey paying a total of $4,185,089.22 for 1,408,218 shares, this is the most they've acquired in one year. In 2017 Jeffrey Allen Bailey cashed out on 8,943 shares for a total of $601,416.75, their largest year based on trade value.